Business Wire

Afton Chemical Launches HiTEC ® 65522 Gasoline Performance Additive Series Approved for TOP TIER+™ Gasoline

26.8.2025 15:16:00 CEST | Business Wire | Press Release

Share

Afton Chemical Corporation, global leader in Gasoline Performance Additives (GPA), is proud to announce the launch of its HiTEC® 65522 GPA series, now approved for use in TOP TIER+™ gasoline. This innovative additive series is designed to meet the evolving needs of modern engine technology, particularly Gasoline Direct Injection (GDI) engines, which are now utilized in 74% of new vehicles in North America, according to the U.S. EPA recent automotive trends report.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250819002273/en/

Afton Chemical Headquarters, Richmond, VA USA

Twenty years ago, a group of original equipment manufacturers (OEMs) established the voluntary TOP TIER™ standard to enhance fuel detergency and optimize engine performance. Recognizing the advancements in engine technology and the need for updated standards, these OEMs have introduced the revised TOP TIER+™ standard. This new standard includes additional requirements to address potential deposit issues in GDI engines, ensuring cleaner and more efficient fuel options.

The new TOP TIER+™ standard, revision G, published in early January, includes two new test methods using a GM LHU engine. The first test evaluates injector deposit control by measuring injector fouling and particulates. Injector fouling can lead to poor spray patterns, compromised fuel delivery, reduced fuel economy, and increased particulate emissions. The second test focuses on protection against stochastic pre-ignition (SPI), a harmful pre-ignition event that can occur in modern downsized engines and potentially lead to engine failure. To learn more about TOP TIER+™, visit www.toptiergas.com.

In anticipation of these changes, Afton Chemical has developed the HiTEC® 65522 GPA series, our most effective chemistry to date. They are specifically formulated to maintain excellent control of intake valve deposits while providing superior deposit control for direct injection engine technology. These additives ensure optimal engine performance and longevity, aligning with the stringent requirements of the new TOP TIER+™ standard.

"We are excited to introduce the HiTEC® 65522 GPA series to the market," said Gerardo Alvarez, Marketing Director for the Americas at Afton Chemical. "Our team has worked diligently to develop an additive that not only meets but exceeds the new TOP TIER+™ requirements. This launch underscores our commitment to providing innovative solutions that support the latest advancements in engine technology."

Afton Chemical is ready to support fuel marketers with the HiTEC® 65522 GPA series. Click here to learn more about how the TOP TIER™ program's new TOP TIER+™ standard enhances fuel quality for Gasoline Direct Injection (GDI) engines, addressing injector deposits and Stochastic Pre-Ignition (SPI) for cleaner, more efficient fuel options.

HiTEC® and Passion for Solutions® are registered trademarks of Afton Chemical Corporation.
TOP TIER™ is a trademark owned by a sponsor of TOP TIER.

About Afton Chemical Corporation

Afton Chemical Corporation is part of the NewMarket Corporation (NYSE: NEU) family of companies, and has been working in the fuel and lubricant additives marketplace for over 100 years. Our technology solutions include additives for Driveline, Engine Oils, Performance and Refinery Fuels, and Industrial applications. We use our formulation, engineering and marketing expertise to help our customers develop and market fuels and lubricants that reduce emissions, improve fuel economy, extend equipment life, improve operator satisfaction and lower the total cost of vehicle and equipment operation. We are focused on developing our technology, meeting specifications, and using our Passion for Solutions® philosophy to provide the differentiation our customers need to stand out. We support our global operations through regional headquarters located in Asia Pacific, EMEAI, Latin America and North America. Afton Chemical Corporation is headquartered in Richmond, Virginia, USA. For more information, visit www.aftonchemical.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250819002273/en/

Contacts

For further information, please contact:
Tim Brennan
Senior Marketing Manager, Fuels
Afton Chemical Corporation
Tim.Brennan@aftonchemical.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Digital Reef Turns to Vertical Farming to Reduce Data Centre Footprint in Partnership With Elevate Farms and Xange.com to Provide Digital Measurement, Reporting and Verification of Project's Environmental Impact Within the Reef Origin Ecosystem23.10.2026 13:12:00 CEST | Press Release

Elevate Farms Inc. and Digital Reef Ltd partnership supports mitigating environmental impact of global data centre expansion establishing a framework for Digital Reef’s infrastructure pipeline to support and utilize environmental assets generated by Elevate Farms' high-yield, closed-loop vertical farming operations. Traditional agriculture supply chains are replaced with optimized indoor facilities significantly reducing food production carbon emissions, water waste and local land constraints. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022393352/en/ Elevate Farms technology offers part of the solution to climate impact isolating food production from traditional agricultural farming variables saving over 95% of standard water requirements and significantly reducing farmland required for equivalent yields and logistical carbon. Digital Reef CEO Piers Slater stated "Digital Reef embrace data centre growth and environment

SLB Announces Third-Quarter 2026 Results23.10.2026 12:50:00 CEST | Press Release

SLB (NYSE: SLB) today announced results for the third-quarter 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261021694458/en/ The exterior of the SLB headquarters in Houston, Texas. Third-Quarter Results (Stated in millions, except per share amounts)Three Months EndedChangeSept. 30, 2026Jun. 30, 2026Sept. 30, 2025SequentialYear-on-yearRevenue $9,449 $8,972 $8,928 5% 6% Income before taxes - GAAP basis $1,019 $1,018 $1,000 0% 2% Income before taxes margin - GAAP basis 10.8% 11.4% 11.2% -57 bps -42 bps Net income attributable to SLB - GAAP basis $735 $786 $739 -6% -1% Diluted EPS - GAAP basis $0.49 $0.52 $0.50 -6% -2% Adjusted EBITDA* $2,067 $1,899 $2,061 9% - Adjusted EBITDA margin* 21.9% 21.2% 23.1% 71 bps -121 bps Pretax segment operating income* $1,576 $1,404 $1,626 12% -3% Pretax segment operating margin* 16.7% 15.6% 18.2% 104 bps -153 bps Net income attributable to SLB, excluding charges & credits* $962 $833 $1,027

EZVIZ’s Smart Entry Solutions Have Consecutively Clinched the European Product Design Award and the Golden Pin Design Award, Indicating a Shift From Home Security to Living Enjoyment23.10.2026 11:58:00 CEST | Press Release

EZVIZ’s smart lock and AI-powered doorbell remained in the spotlight after IFA for bagging two world-class awards. The EP8 Ultra AI-powered video doorbell won the European Product Design Award 2026 (EPDA 2026), keeping leading in user-centric AI. Meanwhile, the DL50FVX smart lock was named the 2026 Golden Pin Design Award (GPDA) laureate for its intuitive access management and entered the finalist of the Best Design Awards. The growing prestige of EZVIZ’s smart home access management lineup marks a new chapter of providing living experiences with multi-level interaction, modern aesthetics, and emotional care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022441786/en/ Two representative models from EZVIZ's smart entry family take home prestigious awards for user-centric innovation. Founded in 2016, the EPDA aims to recognize well-thought-out products that break with tradition and improve everyday life. Continually refres

Galderma’s Relfydess™ (relabotulinumtoxinA) Receives Approval in China for Frown Lines23.10.2026 07:00:00 CEST | Press Release

Galderma (SIX: GALD) today announced that the Chinese NMPA has approved Relfydess for the temporary improvement of moderate-to-severe frown lines in adults, marking a significant expansion of the company’s Injectable Aesthetics portfolio in China – one of the world's largest and fastest-growing aesthetics markets.8,9 This approval follows successful authorizations and launches of Relfydess in more than 35 markets worldwide. Relfydess is the first and only ready-to-use liquid neuromodulator developed with PEARL Technology, designed to deliver a highly active, innovative, complex-free molecule that addresses the real needs of patients and healthcare professionals.1,2,4,5 It is optimized for simple volumetric dosing, without reconstitution, to increase ease-of-use and help ensure consistent dose/volume every time.1,10 At a time whenpatients and healthcare professionals are increasingly seeking high-performance neuromodulators that rapidly deliver long-lasting, natural-looking outcomes, Re

Mundipharma Announces Further Phase III ReSPECT Results Presented as a Late-Breaking Oral Presentation at IDWeek 202622.10.2026 19:03:00 CEST | Press Release

Today Mundipharma announced additional results from the global Phase III ReSPECT clinical trial evaluating REZZAYO®(rezafungin acetate) for prophylaxis of invasive fungal diseases (IFDs) in adult patients undergoing allogeneic haematopoietic stem cell transplantation (allo-HSCT). The Phase III findings were presented today as a late-breaking oral presentation at IDWeek 2026. The presentation provides additional detail following the top line ReSPECT results announced in April 2026, including further endpoint analyses, the components contributing to fungal-free survival (FFS), pre-specified sensitivity analyses and detailed safety outcomes. The additional analyses were consistent with the previously announced topline findings. ReSPECT was a global, multicentre, randomised, double-blind Phase III study in which 402 patients were randomised to rezafungin and 200 to the standard antimicrobial regimen. As previously announced, the study met its primary endpoint, demonstrating non-inferiority

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye